Impact of Early Cardiac Surgery in Severe Left Endocarditis With Neurological Complications: a Retrospective Study
NCT ID: NCT04387513
Last Updated: 2020-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
192 participants
OBSERVATIONAL
2010-08-01
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis Cardiac surgery, as soon as possible, if indicated, would reduce mortality, in severe left endocarditis, with neurological complications.
Primary objective To assess the impact of early versus late cardiac surgery on mortality at 1 year, in patients with severe endocarditis, with neurological complications.
Primary endpoint:
1\) Mortality at 1 year
Secondary endpoints:
1. Analyze the factors associated with neurological degradation
2. Evaluate the neurological tolerance of cardiac surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Valve Surgery Versus Conventional Treatment in Infective Endocarditis Patients With High Risk of Embolism
NCT03718052
Impact of Clinical Care Pathway on Prognosis and Therapeutic Medical Care of Infective Endocarditis
NCT02856607
Early Surgery Versus Conventional Treatment in Infective Endocarditis
NCT00750373
Valvular Aortic Stenosis Prognosis Study
NCT03628313
Sudden Cardiac Death in Systemic Right Ventricle
NCT03833843
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothesis Cardiac surgery, as soon as possible, if indicated, would reduce mortality, in severe left endocarditis, with neurological complications.
Primary objective To assess the impact of early versus late cardiac surgery on mortality at 1 year, in patients with severe endocarditis, with neurological complications.
Primary endpoint:
1\) Mortality at 1 year
Secondary endpoints:
1. Analyze the factors associated with neurological degradation
2. Evaluate the neurological tolerance of cardiac surgery.
Methods Multicentric study (7 French university hospitals). Retrospective study: from august 2010 to december 2017. Propensity score matching study. 192 patients are included.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac surgery
Cardiac surgery, if indicated, delayed or not by neurological complications
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With indication of cardiac surgery
* Severe endocaditis (SOFA score \> or = 3/16)
* With pre operative neurological complications
Exclusion Criteria
* Right endocarditis without left endocarditis
* No severe endocarditis (SOFA score \< 3)
* Ne pre operative neurological complications
* Endocarditis without indication of cardiac surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gros, Alexandre, M.D.
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Alexandre Gros
GROS, Alexandre, Medical Doctor, Intensive Care Unit, Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AlexandreGros
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.